GT200000018A - Procedimiento para preparar secretagogos de hormonas del crecimiento. - Google Patents

Procedimiento para preparar secretagogos de hormonas del crecimiento.

Info

Publication number
GT200000018A
GT200000018A GT200000018A GT200000018A GT200000018A GT 200000018 A GT200000018 A GT 200000018A GT 200000018 A GT200000018 A GT 200000018A GT 200000018 A GT200000018 A GT 200000018A GT 200000018 A GT200000018 A GT 200000018A
Authority
GT
Guatemala
Prior art keywords
formula
procedure
secretagogs
prepare
growth hormones
Prior art date
Application number
GT200000018A
Other languages
English (en)
Inventor
Frank Robert Busch
Charles Kwok-Fung Chiu
Clifford Nathaniel Meltz
Ronald James Post
Peter Robert Rose
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200000018A publication Critical patent/GT200000018A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

ESTA INVENCION SE REFIERE A UN PROCEDIMIENTO MEJORADO PARA PREPARAR COMPUESTOS DE FORMULA II, QUE COMPRENDE ACOPLAR UN COMPUESTO DE FORMULA IV CON UN COMPUESTO DE FORMULA V. SE REFIERE TAMBIEN A UN PROCEDIMIENTO MEJORADO PARA PREPARAR COMPUESTOS DE FORMULA V Y LA POSTERIOR DESPROTECCION DEL COMPUESTO PRTPROTEGIDO RESULTANTE DE FORMULA II. ( EL COMPUESTO DE FORMULA II APARECE AQUI, EN LA CUAL LAS DEFINICIONES DE LAS VARIABLES LETRAS "R" Y LAS OTRAS FORMULAS SE DESCRIBEN EN EL DOCUMENTO ORIGINAL ).
GT200000018A 1999-02-26 2000-02-23 Procedimiento para preparar secretagogos de hormonas del crecimiento. GT200000018A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12274599P 1999-02-26 1999-02-26

Publications (1)

Publication Number Publication Date
GT200000018A true GT200000018A (es) 2001-08-16

Family

ID=22404505

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200000018A GT200000018A (es) 1999-02-26 2000-02-23 Procedimiento para preparar secretagogos de hormonas del crecimiento.

Country Status (44)

Country Link
US (2) US6541634B2 (es)
EP (2) EP1449842A1 (es)
JP (3) JP3437813B2 (es)
KR (2) KR100372063B1 (es)
CN (3) CN1837205A (es)
AP (1) AP1221A (es)
AR (2) AR029617A1 (es)
AT (1) ATE277944T1 (es)
AU (1) AU764122B2 (es)
BG (1) BG104175A (es)
BR (2) BRPI0017522B8 (es)
CA (1) CA2299495C (es)
CO (1) CO5160252A1 (es)
DE (1) DE60014212T2 (es)
DK (1) DK1031575T3 (es)
DZ (1) DZ3018A1 (es)
EA (1) EA003218B1 (es)
EE (1) EE200000193A (es)
ES (1) ES2226712T3 (es)
GT (1) GT200000018A (es)
HK (1) HK1030219A1 (es)
HN (1) HN2000000021A (es)
HR (1) HRP20000103A2 (es)
HU (1) HUP0000907A3 (es)
ID (1) ID24861A (es)
IL (2) IL157103A (es)
IN (1) IN192352B (es)
IS (1) IS5380A (es)
MA (1) MA25072A1 (es)
NO (1) NO20000965L (es)
NZ (1) NZ503062A (es)
OA (1) OA11325A (es)
PA (1) PA8491201A1 (es)
PE (1) PE20001550A1 (es)
PL (1) PL338628A1 (es)
PT (1) PT1031575E (es)
SG (1) SG90096A1 (es)
SI (1) SI1031575T1 (es)
SK (1) SK284982B6 (es)
TN (1) TNSN00035A1 (es)
TR (1) TR200000536A2 (es)
TW (2) TW200718702A (es)
UA (1) UA70306C2 (es)
ZA (1) ZA200000888B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1132388A3 (en) * 2000-03-09 2004-03-03 Pfizer Products Inc. Hexahydropyrazolo[4,3-c]pyridine metabolites
CA2410597A1 (en) 2000-05-30 2001-12-06 Merck & Co., Inc. Melanocortin receptor agonists
AU2003237595A1 (en) * 2003-05-26 2004-12-13 Biocon Limited Process for the preparation of s(+)-2-ethoxy-4-(n-{1-(2-piperidinophelyl)-3-methyl-1- butyl} aminocarbonylmethyl)benzoic acid derivatives
WO2005027913A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a growth hormone secretagogue
US9117477B2 (en) 2013-05-08 2015-08-25 HGST Netherlands B.V. Perpendicular magnetic recording media having novel seed layer
KR102221002B1 (ko) * 2013-05-28 2021-02-26 라퀄리아 파마 인코포레이티드 다형체
CN109320515A (zh) * 2018-11-22 2019-02-12 常州大学 一种Capromorelin手性中间体的不对称合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8610980D0 (en) 1986-05-06 1986-06-11 Ici America Inc Heterocyclic fused tricyclic compounds
GB8901423D0 (en) 1989-01-23 1989-03-15 Fujisawa Pharmaceutical Co Pyrazolopyridine compound and processes for preparation thereof
US5578593A (en) 1992-12-11 1996-11-26 Merck & Co., Inc. Spiro piperidines and homologs promote release of growth hormone
HUT74733A (en) 1993-11-09 1997-02-28 Merck & Co Inc Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone
US5609150A (en) 1995-04-18 1997-03-11 Maged; Jeffrey M. Method for dilating respiratory passages
TW432073B (en) 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
AU2334097A (en) 1996-03-21 1997-10-10 Merck & Co., Inc. 4-spiroindoline piperidines promote release of growth hormone
AU2722297A (en) 1996-04-03 1997-10-22 Merck & Co., Inc. Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone
EP1001970B1 (en) 1997-06-25 2007-03-07 Pfizer Inc. Dipeptide derivatives as growth hormone secretagogues
UA64751C2 (uk) * 1997-06-25 2004-03-15 Пфайзер Продактс Інк. Спосіб лікування інсулінової толерантності речовинами, які посилюють секрецію гормону росту (варіанти) та фармацевтична композиція (варіанти)
UA53716C2 (uk) 1997-06-25 2003-02-17 Пфайзер Продактс Інк. Тартратна сіль заміщеного дипептиду, спосіб її одержання, проміжні сполуки та спосіб їх одержання, фармацевтична композиція (варіанти), спосіб підвищення рівнів ендогенного гормону росту та спосіб лікування або профілактики захворювань (варіанти)

Also Published As

Publication number Publication date
SG90096A1 (en) 2002-07-23
IL134599A (en) 2006-12-10
US6673929B2 (en) 2004-01-06
PE20001550A1 (es) 2001-01-11
TW200718702A (en) 2007-05-16
IL157103A (en) 2007-07-24
US6541634B2 (en) 2003-04-01
PT1031575E (pt) 2004-11-30
BRPI0017522A2 (es) 2009-12-22
DE60014212T2 (de) 2005-12-15
HUP0000907A2 (en) 2001-03-28
AP2000001754A0 (en) 2000-03-31
BG104175A (bg) 2000-12-29
HK1030219A1 (en) 2001-04-27
JP2000247974A (ja) 2000-09-12
US20030158414A1 (en) 2003-08-21
PA8491201A1 (es) 2001-04-30
BRPI0017522B1 (pt) 2013-09-24
EA200000172A2 (ru) 2000-08-28
JP4051314B2 (ja) 2008-02-20
DK1031575T3 (da) 2005-01-03
IN192352B (es) 2004-04-10
ID24861A (id) 2000-08-31
JP2003327585A (ja) 2003-11-19
ES2226712T3 (es) 2005-04-01
AR029617A1 (es) 2003-07-10
EP1031575A1 (en) 2000-08-30
US20020002283A1 (en) 2002-01-03
ATE277944T1 (de) 2004-10-15
DZ3018A1 (fr) 2004-03-20
CA2299495C (en) 2010-06-15
HUP0000907A3 (en) 2001-05-28
NZ503062A (en) 2001-07-27
CN1270960A (zh) 2000-10-25
IL134599A0 (en) 2001-04-30
HU0000907D0 (en) 2000-04-28
IS5380A (is) 2000-08-27
KR20020065455A (ko) 2002-08-13
EA003218B1 (ru) 2003-02-27
NO20000965L (no) 2000-08-28
KR100372063B1 (ko) 2003-02-14
EE200000193A (et) 2000-10-16
EP1031575B1 (en) 2004-09-29
NO20000965D0 (no) 2000-02-25
BRPI0017522B8 (pt) 2021-05-25
JP3437813B2 (ja) 2003-08-18
TWI286142B (en) 2007-09-01
JP2003261565A (ja) 2003-09-19
IL157103A0 (en) 2004-02-08
CN1515570A (zh) 2004-07-28
SK2302000A3 (en) 2000-11-07
OA11325A (en) 2003-10-27
AP1221A (en) 2003-11-03
HN2000000021A (es) 2001-02-02
HRP20000103A2 (en) 2001-04-30
PL338628A1 (en) 2000-08-28
BRPI0000967B8 (pt) 2021-12-07
BRPI0000967A (pt) 2001-09-11
EA200000172A3 (ru) 2000-10-30
TNSN00035A1 (fr) 2005-11-10
SK284982B6 (sk) 2006-03-02
KR20010006698A (ko) 2001-01-26
AU1947100A (en) 2000-08-31
DE60014212D1 (de) 2004-11-04
CN1837205A (zh) 2006-09-27
AR053722A2 (es) 2007-05-16
BRPI0000967B1 (pt) 2012-06-12
CN1137891C (zh) 2004-02-11
ZA200000888B (en) 2001-08-23
CA2299495A1 (en) 2000-08-26
UA70306C2 (en) 2004-10-15
MA25072A1 (fr) 2000-10-01
KR100361783B1 (ko) 2002-11-22
SI1031575T1 (en) 2005-02-28
AU764122B2 (en) 2003-08-07
EP1449842A1 (en) 2004-08-25
CO5160252A1 (es) 2002-05-30
TR200000536A2 (tr) 2000-09-21

Similar Documents

Publication Publication Date Title
ITRM20010464A1 (it) Derivati retinoidi ad attivita' antiangiogenica, antitumorale e pro-apoptotica.
MY126559A (en) Fungicidal 2-methoxybenzophenones
PA8527001A1 (es) Poliarilcarboxamidas utiles como agentes reductores de lipidos
HN1999000154A (es) 1,2,3,4 tetrahidroquinolinas 2 sustituidas 4 - carboxiamino sustituidas.
CL2003002770A1 (es) Compuestos derivados de pirrol e imiddazol; composiciones farmaceuticas que los contienen; procedimiento de preparacion; y su uso en el tratamiento y/o prevencion de enfermedades que estan asociadas con la modulacion de los receptores a canabinoides
PA8578601A1 (es) Derivados de 2,2- difenil-benzodioxol
DE69803907D1 (de) Fungizide 2-Methoxybenzophenone
GT200000190A (es) Procedimiento para la obtencion de 1,2,3,4-tetrahidroquinolinas-4-carboxiamino-2-sustituidas.
AR031975A1 (es) Compuestos analogos de (1r,cis)-4-(6-amino-9h-purin-9-il) -2-ciclopenteno-1-metanol, proceso para su preparacion, su uso en el tratamiento de infecciones virales, y envase que los contiene
ES2165523T3 (es) Derivados de la ciclopentano-1,3-diona.
CO5601045A2 (es) Procedimiento para la fabricacion de compuestos organicos
ES2188984T3 (es) Procedimiento de enriquecimiento en r de epimeros de derivados de 16,17-acetales de derivados de 21-aciloxi-pregnano-1,4-dieno-11-beta, 16alfa-triol-3,20-dionas.
CY1106622T1 (el) Σταθεροποιηση ραδιοφαρμακευτικων συνθεσεων χρησιμοποιωντας υδροφιλικους θειοαιθερες και υδροφιλικες 6-υδροξυ χρωμανες
GT200000018A (es) Procedimiento para preparar secretagogos de hormonas del crecimiento.
SV1999000060A (es) Procedimiento para la preparacion de (s,s)-bencil-2,8-diazabiciclo 4.3.0 nonano ref. 32965-sv
AR008539A1 (es) PROCESO PARA LA PREPARACIoN DE DERIVADOS DE TIAZOL, INTERMEDIARIOS DEL MISMO Y PROCEDIMENTO PARA LA PREPARACIoN DE INTERMEDIARIOS
BR9902084A (pt) Heterociclos.
UY26954A1 (es) Procedimiento para preparar 3-amino-2-cloro-4-metilpiridina
DK1204659T3 (da) Serotonerge benzofuraner
ES2185196T3 (es) Un procedimiento para la preparacion de tetraazamacrociclos.
ES2171906T3 (es) Procedimiento de biotransformacion de compuestos colchicinoides en los correspondientes derivados 3-glucosilo.
ES2177877T3 (es) Procedimiento para la fabricacion de 1,4-bis(aminometil)ciclohexano.
ES2163316T3 (es) Procedimiento para la alquilacion de sulfonamidas impedidas.
ES2166045T3 (es) Procedimiento para la preparacion de compuestos de 4,6-bis(ariloxi)pirimidina asimetricos.
AR023979A1 (es) Procesos para preparar compuestos intermedios de plaguicidas